Polymerase chain reaction-based diagnosis of del(5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval

Blood

Volumn 88, Issue 7, 1996, Pages 2665-2670

  Horrigan, Stephen K ^b   Westbrook, Carol A ^a   Kim, Anne H ^b   Banerjee, Mekhala ^b   Stock, Wendy ^b   Larson, Richard A ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME 5Q; GENE DELETION; HUMAN; HUMAN TISSUE; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029796608     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.7.2665.bloodjournal8872665     Document Type: Article

References (23)

1. Van den Berghe H, Cassiman JJ, David G, Fryns JP, Michaux JL, Sokal G: Distinct hematological disorder with deletion of long arm of no. 5 chromosome. Nature 251:437, 1974
2. Nimer SD, Golde DW: The 5q- abnormality. Blood 70:1705, 1987
3. Vardiman JW, Coelho A, Golomb HM, Rowley J: Morphologic and cytochemical observations on the overt leukemia phase of therapy-related leukemia. Am J Clin Pathol 79:525, 1983
4. Pedersen-Bjergaard J, Philip P, Larsen SO, Jensen G, Byrsting K: Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 76:1083, 1990
5. Larson RA, Le Beau MM, Vardiman JW, Testa JR, Golomb HM, Rowley JD: The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: A 12-year study 1970-1982. Cancer Genet Cytogenet 10:219, 1983
6. Fourth International Workshop on Chromosomes in Leukemia, Clinical significance of chromosomal abnormalities in acute nonlymphocytic leukemia. Cancer Genet Cytogenet 11:332, 1984
7. Samuels BL, Larson RA, Le Beau MM, Daly KM, Bitter MA, Vardiman JW, Barker CM, Rowley JD, Golomb HM: Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlating with drug susceptibility in vivo. Leukemia 2:79, 1988
8. Schiffer CA, Lee EJ, Tomiyasu T, Wiernik PH, Testa JR: Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood 73:263, 1989
9. Boultwood, J, Fidler C: Chromosomal deletions in myelodysplasia. Leuk Lymphoma 17:71, 1995
10. Le Beau MM, Espinosa III, R, Neuman WL, Stock W, Roulston D, Larson RA, Keinanen M, Westbrook CA: Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in myeloid leukemias. Proc Natl Acad Sci USA 90:5484, 1993
11. Boultwood J, Fidler C, Lewis S, Kelly S, Sheridan H, Littlewood TJ, Buckle VJ, Wainscoat JS: Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q-syndrome: Delineation of the critical region on 5q and identification of a 5q- breakpoint. Genomics 19:425, 1994
12. Nagarajan L, Zavadil J, Claxton D, Lu X, Fairman J, Warrington J, Wasmuth JJ, Chinault AC, Server CE, Slovak ML, Willman CL, Deisseroth AB: Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in Patients with 5q- chromosome Blood 83:199, 1994
13. Pedersen B: 5q-: Pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment. Anticancer Res 13:1913, 1993
14. Fairman J, Chumakov I, Chinault AC, Nowell PC, Nagarajan L: Physical mapping of the minimal region of loss in 5q- chromosome. Proc Natl Acad Sci USA 92:7406, 1995
15. Richards B, Skoletsky J, Shuber AP, Balfour R, Stern RC, Dorkin HL, Parad RB, Witt D, Klinger KW: Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosome 5 and 7 in malignant myeloid disorders. Blood 79:1501, 1992
16. Richards B, Skoletsky J, Shuber AP, Balfour R, Stern RC, Dorkin HL, Parad RB, Witt D, Klinger KW: Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet 2:159, 1993
17. Sambrook J, Fritch ER, Maniatis T: Isolation of high molecular-weight DNA from mammalian cells, in Molecular Cloning: A laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989, p 9.14
18. Sheffield VC, Weber JL, Buetow KH, Murray JC, Even DA, Wiles K, Gastier JM, Pulido JC, Yandava C, Sunden SL, Mattes G, Businga T, McClain A, Beck J, Scherpier T, Gilliam J, Zhong J, Duyk GM: A collection of tri- and tetranucleotide repeat markers used to generate high quality, high resolution human genome-wide linkage maps. Hum Mol Genet 4:1837, 1995
19. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Lathrop M, Weissenbach J: The 1993-4 Genethon human genetic linkage map. Nat Genet 7:246, 1994
20. Polymeropoulos MH, Xiao H, Rath DS, Merril CR: Dinucleotide repeat polymorphism the human interleukin 9 gene. Nucleic Acids Res 19:688, 1991
21. Weissenbach J, unpublished data. Whitehead Institute/MIT Center for Genome Research, Human Genetic Mapping Project
22. The Utah Marker Development Group, A collection of ordered tetranucleotide-repeat markers from the human genome. Am J Hum Genet 57:619, 1995
23. Kroef MJ, Fibbe WE, Mout R, Jansen RPM, Haak HL, Wessels JW, Van Kamp H, Willemze R, Landegent JE: Myeloid but not lymphoid cells carry the 5q deletion: Polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions. Blood 81:1849, 1993